Commonwealth Equity Services LLC boosted its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 95.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 46,192 shares of the technology company’s stock after acquiring an additional 22,527 shares during the period. Commonwealth Equity Services LLC’s holdings in Veeva Systems were worth $13,761,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Veeva Systems by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 14,971,425 shares of the technology company’s stock worth $4,311,471,000 after purchasing an additional 210,859 shares during the period. Alliancebernstein L.P. grew its position in Veeva Systems by 3.7% during the second quarter. Alliancebernstein L.P. now owns 5,705,648 shares of the technology company’s stock worth $1,643,113,000 after buying an additional 205,997 shares during the period. JPMorgan Chase & Co. grew its position in Veeva Systems by 2.6% during the second quarter. JPMorgan Chase & Co. now owns 3,316,274 shares of the technology company’s stock worth $955,030,000 after buying an additional 85,516 shares during the period. Geode Capital Management LLC increased its holdings in Veeva Systems by 3.8% in the second quarter. Geode Capital Management LLC now owns 3,092,539 shares of the technology company’s stock valued at $888,108,000 after buying an additional 114,003 shares in the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of Veeva Systems by 111.7% during the 2nd quarter. AQR Capital Management LLC now owns 1,838,046 shares of the technology company’s stock valued at $526,508,000 after acquiring an additional 969,905 shares during the period. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems News Roundup
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Board-authorized buyback and new cloud launch: Veeva authorized up to US$2 billion to repurchase Class A shares and announced a new cloud offering—news that analysts and investors cited as the main reason for the earlier price jump. Why Veeva Systems (VEEV) Is Up 8.0% After US$2 Billion Buyback And New Cloud Launch
- Positive Sentiment: Large pharma customer commitment — Novo Nordisk expanded its commitment to Veeva Vault CRM for international operations, signaling strong enterprise demand and validation from a major global drugmaker. [PRNewswire] Novo Nordisk International Operations Commits to Veeva Vault CRM
- Positive Sentiment: Strategic partnership with BioMarin: A long-term deal to modernize development and commercialization workflows increases Veeva’s addressable services and tightens customer relationships—likely to support recurring revenue. Veeva and BioMarin Form Long-Term Strategic Partnership
- Positive Sentiment: Product expansion — Veeva launched an Environmental Monitoring solution to modernize manufacturing quality control, expanding its manufacturing QC suite and upsell potential within life-science customers. Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
- Positive Sentiment: Analyst sentiment improving: Truist upgraded Veeva from Hold to Buy and Stifel issued a buy—upgrades that can boost demand from institutional investors and support the valuation multiple.
- Neutral Sentiment: Investor events and visibility: Veeva is scheduled to present at the J.P. Morgan 2026 Healthcare Conference, giving management an opportunity to highlight strategy and guidance to active investors. Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
- Neutral Sentiment: Long-term performance stories and market pages (background/context) are circulating, but they’re more narrative than immediate catalysts. Here’s how much you’d have if you invested $1000 in Veeva Systems a decade ago
Analyst Ratings Changes
Get Our Latest Report on Veeva Systems
Veeva Systems Stock Performance
Shares of VEEV opened at $240.31 on Friday. Veeva Systems Inc. has a one year low of $201.54 and a one year high of $310.50. The company has a market capitalization of $39.50 billion, a P/E ratio of 46.75, a P/E/G ratio of 1.77 and a beta of 1.07. The stock has a 50-day moving average price of $246.97 and a 200 day moving average price of $271.04.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The business had revenue of $0.81 million for the quarter, compared to the consensus estimate of $792.37 million. During the same quarter last year, the business posted $1.75 EPS. The business’s revenue was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. As a group, equities research analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.
Veeva Systems announced that its Board of Directors has initiated a stock buyback program on Monday, January 5th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the technology company to purchase up to 5.5% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its shares are undervalued.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Read More
- Five stocks we like better than Veeva Systems
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
